Avidity Biosciences (RNA)
(Delayed Data from NSDQ)
$24.36 USD
+0.53 (2.22%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.34 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Earnings News For RNA
-
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates
-
Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
-
Avidity Biosciences Reports Third Quarter 2023 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q1 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Lags Revenue Estimates
-
Avidity Biosciences, Inc. (RNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
Avidity Biosciences, Inc. (RNA) Reports Q1 Loss, Tops Revenue Estimates
-
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Lags Revenue Estimates
-
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Avidity Biosciences, Inc. (RNA) Q3 Earnings Expected to Decline
-
Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Tops Revenue Estimates
-
Will Avidity Biosciences, Inc. (RNA) Report Negative Q2 Earnings? What You Should Know